Global Theranostics Market

Global Theranostics Market is expected to reach $XX Mn by 2026 from $XX Mn in 2019, at a CAGR of 10.5% during forecast period.

Global Theranostics Market by Regional
Global Theranostics Market Overview:

Theranostics is a combination of diagnosis and therapeutics, which involves nanoscience to unite diagnostic and therapeutic applications to form a single agent. The approach of Theranostics is targeted, safe and efficient pharmacotherapy. Theranostics helps in optimizing safety, effective results, and streamlining drug development. It provides a transition from conventional medicine to Theranostics.
Global Theranostics Market Dynamics:

Ongoing advances in the field of cancer therapy to overcome the side effects of conventional treatment methods will drive the theranostics market growth.

The rising prevalence of chronic diseases and the demand for innovative chemotherapeutic treatments and the need for improving disease detection are the key factors propelling the global theranostics market. In 2017, Illumina, Inc. announced the launch of the U.S. Food & Drug Administration (FDA) approved an extended RAS panel for identification of patients eligible for treatment of metastatic colorectal cancer with Vectibix (panitumumab). Reduced time for medical trials and increasing collaboration between drugs and diagnostics firms are expected to contribute to the market growth. Also, the rising use of potential and clinically adaptable nanomaterials in the biological imaging area and therapy is expected to bolster the market growth. In 2018, Biocartis Group NV and Amgen Inc. partnered to develop companion diagnostic test for Amgen’s drug Veectibix.

The report has profiled fourteen key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed.
Global Theranostics Market Segment Analysis:

The global Theranostics Market is segmented on the basis of Therapeutic area and Technology.

Based on Therapeutic Area, the oncology segment is held largest share XX% of the global theranostics market in 2019. The segment is estimated to grow at a CAGR of 10. 3% throughout the forecast period. Owing to increasing cancer cases and theranostics potentials to make effective cancer care are the factors associated with the market growth. According to WHO (World Health Organization), in 2018, cancer is the second leading cause of death globally, and an estimated 9.6 million people died. Globally, about 1 in 6 deaths is due to cancer.

Global Theranostics Market by Area

To know about the Research Methodology :- Request Free Sample Report
Global Theranostics Market Regional Insights:

Global Theranostics Market by Regional
North America is expected to dominate the global market during forecast period.

Owing to the rising incidence of severe diseases like neurological disorders and cancer is the prime factor driving the market growth. According to National Cancer Institutes, in 2018, an estimated 1,735,350 new cases of cancer were diagnosed in the US. Also, the availability of advanced healthcare infrastructure, strong R&D activities, and increasing collaborations are fueling the market in the region.
APAC is expected to grow at a faster pace during forecast period.

Owing to increasing awareness and adoption of companion diagnostics, especially for cancers. Global companies are also highly focusing on forming partnerships and collaborations with local players which will help in better market growth. In August 2018, Qiagen formed a collaboration with SRL Inc., a Japanese clinical lab testing company for introduction of new companion diagnostics with novel drug approvals.

The report also helps in understanding Global Theranostics Market dynamics, structure by analyzing the market segments and project the Global Theranostics Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Theranostics Market make the report investor’s guide.
Global Theranostics Market Scope: Inquire before buying

Global Theranostics Market by Scope
Global Theranostics Market, by Region:

• North America
• Europe
• South America
• MEA
• APAC
Global Theranostics Market Key Players:

• F Hoffman La Roche
• Thermo Fisher Scientific Inc.
• GE Healthcare
• Agilent Technologies
• Qiagen NV
• Foundation Medicine
• Leica Biosystems Nussloch GmBH
• Pfizer, Inc.
• Beckman Coulter, Inc.
• Focus Diagnostics
• Illumina, Inc.
• Abbott Laboratories
• Myriad Genetics, Inc.
• AmeriPath, Inc.

About This Report
Report ID 91676
Category Healthcare
Published Date April 2021
Updated Date
Report Payment
Single User $ 4100
Corporate User $ 5900
Related Reports
For More Information Visit @: https://www.maximizemarketresearch.com/market-report/global-theranostics-market/91676/

This Report Is Submitted By :Maximize Market Research Company

Customization of the report:

Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Leave a Comment

Show Buttons
Hide Buttons